Apollo Hospitals to Fully Acquire AHLL for ₹12.5 Billion, Plans ₹5.7 Billion Oncology Centre in Gurugram

Apollo Hospitals Enterprise Ltd. on Friday said it will acquire International Finance Corp.’s 31% stake in its subsidiary Apollo Health and Lifestyle Ltd. (AHLL) for ₹12.5 billion, making it a 100% subsidiary. After the deal, Apollo Hospitals will hold 99.4% in AHLL, with the balance 0.6% owned by employees under the stock ownership plan.

The company said the complete takeover will bring sharper capital allocation, operational synergies, and stronger returns. “This acquisition is a decisive step that will allow for sharper capital allocation and a greater focus on select high-potential segments,” Managing Director Suneeta Reddy said.

AHLL will continue to focus on four verticals: primary care and diagnostics, birthing and women’s health centres, ambulatory care centres, and dialysis and dental networks.

Separately, Apollo Hospitals announced plans to set up a 100-bed oncology centre at Gurugram, featuring next-generation proton therapy, with an investment of ₹5.7 billion. The project is part of the Phase 2 expansion of its upcoming 500-bed hospital in the city.

The first phase is expected to be commissioned by January–June next year, while the cancer centre is targeted for completion in four years. This will be Apollo’s third proton therapy facility in India.